Abstract: Predicting clinical outcomes, particularly mortality risk, is a crucial aspect of patient care and management in the medical field. Numerous studies have employed various methods to improve ...

Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with ...

1 College of Life and Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China 2 Department of Neurology, Dazhou Central Hospital, Dazhou, China Background: Post-stroke epilepsy ...

Introduction Safe surgical care is a cost-effective intervention for addressing a wide range of conditions, yet postoperative complications remain a leading global cause of disability, mortality and ...

1 Department of Radiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China 2 Medical Imaging Research Center, Anhui Medical University, Hefei, China Objective: Despite the ...

When Judith Miller had routine blood work done in July, she got a phone alert the same day that her lab results were posted online. So, when her doctor messaged her the next day that her overall tests ...

ABSTRACT: This paper aims to investigate the effectiveness of logistic regression and discriminant analysis in predicting diabetes in patients using a diabetes dataset. Additionally, the paper ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Logistic Properties of the Americas ( ...

SAN JOSÉ, Costa Rica--(BUSINESS WIRE)--Logistic Properties of the Americas (NYSE American: LPA) (together with its subsidiaries, “LPA” or the “Company”), announced today its unaudited consolidated ...

Have you ever wondered how a tool as familiar as Microsoft Excel could still surprise you? For decades, Excel has been the go-to platform for crunching numbers, analyzing data, and organizing ...

AVO combination showed higher undetectable MRD rates than acalabrutinib and venetoclax or chemoimmunotherapy, with sustained benefits up to 36 months post-therapy. Cross-trial comparisons indicated a ...